Alcimed, an innovation and new business consulting firm, remains committed to supporting the pharmaceutical industry in untangling the complex web of difficulties behind curing Alzheimer’s, a disease with one of the highest drug clinical trial failure rates.
Zee. Aero, Kitty Hawk, Ehang, Terrafugia, and now Airbus: many players are rushing to the “flying cars” market. The concept is receiving an increasing support from the institutional, industrial and financial worlds. It is gaining in maturity, and some start-ups promise to take it to the market next year. However, it remains certain that this market will not take off before a long time.
With the emergence of new technologies, the ageing population and the increasing of chronic diseases, the hospital, as known today, will go through massive changes in the next twenty years. Alcimed imagines the three wings that might constitute the hospital of the future in 2035.
Alcimed, an innovation and new business consulting firm, dives into the success of a unique healthcare business model rooted in Mexico, presenting a new competition to pharmaceutical companies in Latin America.
Alcimed establishes a new foreign subsidiary in Singapore to develop its client’s uncharted territories
Alcimed, an Innovation and New Business consulting firm, strengthens its international presence by setting up a new subsidiary in Singapore. The purpose is to get closer to its current European and American customers, in the Healthcare and Agri-food industry, such as Sanofi, Johnson & Johnson, Boehringer Ingelheim, Nestle, and General Mills, which have headquarters in Asia.
Alcimed, an Innovation and New Business consulting firm, has just been ranked among the Top 5 consulting firms in the Health-Pharma sector by Capital Magazine (published in the October 2016 issue) in a survey conducted on consulting services.
Alcimed, an innovation and new business consulting firm, looks at the causes and consequences of non-adherence to medications and stresses the necessity to develop efficient solutions to what is arguably the most important unmet need across the entire healthcare ecosystem.
Alcimed, an innovation and new business consulting firm, presents the potential use and risk of the blockchain in healthcare.
Alcimed, an innovation and new business consulting firm, assesses the impact of the Pharma supply chain transformation resulting from the Drug Supply Chain Security Act.
Open innovation, or the ability to innovate beyond one's usual boundaries, has gained in importance during the last 10 years with the deployment of digital tools. In particular, we see it represented today by various forms of partnerships between large groups and players in their ecosystems, especially with start-ups. For these 'win – win' partnerships to become sustainable, traditional working processes must be optimised.
Aquaponics – combination of aquaculture and hydroponics – was initially developed in response to the problems raised by intensive aquaculture. It may also become an alternative development route to conventional agriculture.
The booming research on skin microbiome is the source of important discoveries on its role in the maintenance of healthy skin. These findings open up possibilities for innovation in cosmetics, with products that will ensure a proper balance of this ecosystem.
Nutrition and public health: The strengthened role of the food processing industries in public health problems
The prevalence of conditions partly related to diet, such as obesity (the worldwide prevalence of which has doubled since 19801), but also diabetes, cardiovascular diseases, certain cancers, etc., is growing constantly. Facing this trend, the food Industry is increasingly involved in the search for solutions. Alcimed, consultants in innovation and development of new markets, is looking into the positioning of food industries against the public health issues link to nutrition.
Singapore: Fertile ground for innovation in construction, driven by state policies to increase productivity
The Singapore government strongly encourages innovative construction techniques in order to improve productivity and reduce labor on site. Alcimed, a consulting firm in exploration of new markets, releases an update on these innovations, including advanced precast and digitization of construction projects.
With the aim of improving public health, many national and international bodies are asking companies to limit the sugar intake of adults and children, encouraging them to reduce the quantity of added sugar, not only in drinks but also in solid foods. Alcimed, consultants in innovation and development of new markets, analyses the ability of the food-processing industry to face up to this issue.
The increasing demand in emerging countries, the changing business landscape, the development of new vaccines and the appearance of new technologies for their administration are transforming the world of vaccines. Alcimed, consultants in innovation and development of new markets, reviews the change in the world vaccine market.
The technique of 3D printing has become an essential production process in the healthcare sector, where it enables unequalled customisation of the therapeutic arsenal. Alcimed, consultants in innovation and development of new markets, is considering the various applications of 3D printing in healthcare and the prospects that it offers for a profoundly-changing sector that could require the economic models in use today to be rethought.
The connected objects are more and more part of our daily lives: computers, mobile phones, but also watches, clothing and countless sensors for the home or the car. These technologies are changing the functioning of our society and our way of life. Originally associated to the consumer sphere, the Internet of Things (IoT) is more and more interesting for industrials.
To optimise the R&D expenditure and support growth, pharmaceutical companies must alter their strategies. They are resorting increasingly to external innovation and particularly crowdsourcing to enable them to maintain or supplement their product pipelines.
In a relatively unproductive environment of the pharmaceutical industry, translational research offers prospects for privileged innovation and challenges the way research is currently organised. Alcimed, consultants in innovation and development of new markets, raises the issues of translational research and its impact on the development of new treatments for patients.